1. Bombardier, C., Tugwell, P., Sinclair, A., Dok, C., Anderson, G., Buchanan, W.W. Preference for endpoint measures in clinical trials: results of structured workshops. J Rheumatol 1982, 9, 5, 798–801.
2. Spector, T.D. Epidemiological aspects of studying outcome in rheumatoid arthritis. Br J Rheumatol 1988, 27 (Suppl. I), 5–11.
3. Altman, R.D., Meenan, R.F., Hochberg, M.C., Bole, G.G.Jr., Brandt, K., Cooke, T.D.V., Greenwald, R.A., Howell, D.S., Kaplan, D., Koopman, W.J., Mankin, H., Mikkelsen, W.M., Moskowitz, R., Sokoloff, L. An approach to developing criteria for the clinical diagnosis and classification of osteoarthritis: A status report of the American Rheumatism Association Diagnostic Subcommittee on Osteoarthritis. J Rheumatol 1983, 10, 2, 180–183.
4. Bellamy, N., Buchanan, W.W. Outcome measurement in osteoarthritis clinical trials: the case for standardisation. Clin Rheumatol 1984, 3, 3, 293–303.
5. Guidelines for the clinical evaluation of anti-inflammatory and antirheumatic drugs (adults and children). US Department of Health and Human Services, Public Health Service, Food and Drug Administration, April 1988, 12–15.